ProPhase Labs Current Valuation vs. Shares Owned By Insiders
| PRPH Stock | USD 0.77 0.01 1.28% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.58 | 0.3659 |
|
|
For ProPhase Labs profitability analysis, we use financial ratios and fundamental drivers that measure the ability of ProPhase Labs to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well ProPhase Labs utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between ProPhase Labs's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of ProPhase Labs over time as well as its relative position and ranking within its peers.
ProPhase |
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ProPhase Labs. If investors know ProPhase will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ProPhase Labs listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.95) | Earnings Share (1.53) | Revenue Per Share 0.996 | Quarterly Revenue Growth (0.81) | Return On Assets (0.23) |
The market value of ProPhase Labs is measured differently than its book value, which is the value of ProPhase that is recorded on the company's balance sheet. Investors also form their own opinion of ProPhase Labs' value that differs from its market value or its book value, called intrinsic value, which is ProPhase Labs' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ProPhase Labs' market value can be influenced by many factors that don't directly affect ProPhase Labs' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ProPhase Labs' value and its price as these two are different measures arrived at by different means. Investors typically determine if ProPhase Labs is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ProPhase Labs' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
ProPhase Labs Shares Owned By Insiders vs. Current Valuation Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining ProPhase Labs's current stock value. Our valuation model uses many indicators to compare ProPhase Labs value to that of its competitors to determine the firm's financial worth. ProPhase Labs is rated below average in current valuation category among its peers. It also is rated below average in shares owned by insiders category among its peers . The ratio of Current Valuation to Shares Owned By Insiders for ProPhase Labs is about 3,324,406 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the ProPhase Labs' earnings, one of the primary drivers of an investment's value.ProPhase Current Valuation vs. Competition
ProPhase Labs is rated below average in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is at this time estimated at about 10.06 Billion. ProPhase Labs adds roughly 47.64 Million in current valuation claiming only tiny portion of equities under Health Care industry.
ProPhase Shares Owned By Insiders vs. Current Valuation
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
ProPhase Labs |
| = | 47.64 M |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
ProPhase Labs |
| = | 14.33 % |
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
ProPhase Shares Owned By Insiders Comparison
ProPhase Labs is currently under evaluation in shares owned by insiders category among its peers.
ProPhase Labs Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in ProPhase Labs, profitability is also one of the essential criteria for including it into their portfolios because, without profit, ProPhase Labs will eventually generate negative long term returns. The profitability progress is the general direction of ProPhase Labs' change in net profit over the period of time. It can combine multiple indicators of ProPhase Labs, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | -300 K | -315 K | |
| Operating Income | -21.6 M | -20.5 M | |
| Net Loss | -16.8 M | -15.9 M | |
| Income Tax Expense | -6 M | -5.7 M | |
| Income Before Tax | -22.8 M | -21.7 M | |
| Total Other Income Expense Net | -1.2 M | -1.1 M | |
| Net Income Applicable To Common Shares | 7.2 M | 7.6 M | |
| Net Loss | -10.5 M | -10 M | |
| Non Operating Income Net Other | 71.3 K | 74.9 K | |
| Interest Income | 69 K | 65.5 K | |
| Net Interest Income | -841 K | -799 K | |
| Change To Netincome | 10.8 M | 11.3 M | |
| Net Loss | (0.98) | (0.93) | |
| Income Quality | 0.68 | 0.65 | |
| Net Income Per E B T | 0.74 | 0.77 |
ProPhase Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on ProPhase Labs. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of ProPhase Labs position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the ProPhase Labs' important profitability drivers and their relationship over time.
Use ProPhase Labs in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if ProPhase Labs position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ProPhase Labs will appreciate offsetting losses from the drop in the long position's value.ProPhase Labs Pair Trading
ProPhase Labs Pair Trading Analysis
The ability to find closely correlated positions to ProPhase Labs could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace ProPhase Labs when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back ProPhase Labs - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling ProPhase Labs to buy it.
The correlation of ProPhase Labs is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as ProPhase Labs moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if ProPhase Labs moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for ProPhase Labs can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your ProPhase Labs position
In addition to having ProPhase Labs in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Treasury ETFs Thematic Idea Now
Treasury ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Treasury ETFs theme has 114 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Treasury ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Your Equity Center. For more detail on how to invest in ProPhase Stock please use our How to Invest in ProPhase Labs guide.You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
To fully project ProPhase Labs' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of ProPhase Labs at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include ProPhase Labs' income statement, its balance sheet, and the statement of cash flows.